...
首页> 外文期刊>Clinical and experimental allergy : >Allergen bronchoprovocation and chitinases in allergic asthma
【24h】

Allergen bronchoprovocation and chitinases in allergic asthma

机译:过敏性哮喘中的过敏原支气管激发和几丁质酶

获取原文
获取原文并翻译 | 示例
           

摘要

Allergen bronchoprovocation is one of the few interventions which can induce a controlled exacerbation of disease in a laboratory setting, and it has been invaluable as a research tool for investigation of upper and lower respiratory tract allergic diseases. Bronchial challenges can be administered by inhalation of an allergen extract as a high dose challenge on a single day, as low doses of allergen across several days, or as a segmental challenge where allergen is instilled directly in the airways by bronchoscopy. All of these challenges are well standardized and induce clinical expressions of asthma, including variable airway obstruction and airway hy-perresponsiveness, which are associated with airway inflammation and structural alterations in the airways.
机译:过敏原支气管激发是在实验室环境中可诱发疾病受控加剧的少数干预措施之一,作为研究上呼吸道和下呼吸道过敏性疾病的研究工具,其价值很高。支气管激发可通过吸入过敏原提取物进行,以高剂量激发,一天,低剂量变应原,几天,或分段激发,通过支气管镜直接将过敏原滴入气道。所有这些挑战均得到了很好的标准化,并诱发了哮喘的临床表现,包括可变的气道阻塞和气道高反应性,这些症状与气道炎症和气道结构改变有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号